{"disease":{"id":"non-disabling-stroke","name":"non disabling stroke"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00885456","title":"Program of Rehabilitative Exercise and Education to Avert Vascular Events After Non-disabling Stroke or Transient Ischemic Attack: A Multi-site RCT","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":187,"lead_sponsor_name":"Marilyn MacKay-Lyons","has_results":false},{"nct_id":"NCT03004820","title":"Prevention of Ischemic Conditions in Non-disabling Stroke/Transient Ischemic Attack With Remote Ischemic Conditioning","phase":"NA","overall_status":"COMPLETED","enrollment_count":167,"lead_sponsor_name":"Capital Medical University","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}